000 01799 a2200529 4500
005 20250513090044.0
264 0 _c19960524
008 199605s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-199604000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKonski, A A
245 0 0 _aClinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cApr 1996
300 _a164-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xgenetics
650 0 4 _aAdenocarcinoma, Clear Cell
_xgenetics
650 0 4 _aAneuploidy
650 0 4 _aCystadenocarcinoma, Papillary
_xgenetics
650 0 4 _aDNA, Neoplasm
_xanalysis
650 0 4 _aDiploidy
650 0 4 _aDisease Progression
650 0 4 _aEndometrial Neoplasms
_xgenetics
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aHysterectomy
650 0 4 _aLymphatic Metastasis
_xgenetics
650 0 4 _aNeoplasm Staging
650 0 4 _aPolyploidy
650 0 4 _aPrognosis
650 0 4 _aReceptors, Estrogen
_xanalysis
650 0 4 _aReceptors, Progesterone
_xanalysis
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
650 0 4 _aUterine Neoplasms
_xgenetics
700 1 _aDomenico, D
700 1 _aIrving, D
700 1 _aTyrkus, M
700 1 _aNeisler, J
700 1 _aPhibbs, G
700 1 _aMah, J
700 1 _aEggleston, W
773 0 _tAmerican journal of clinical oncology
_gvol. 19
_gno. 2
_gp. 164-8
856 4 0 _uhttps://doi.org/10.1097/00000421-199604000-00015
_zAvailable from publisher's website
999 _c8609689
_d8609689